EuroPCR 2024: Late-Breaking Science Video Collection

Up Next

EuroPCR 2024: Late-Breaking Science Video Collection

Average (ratings)
No ratings
Your rating
About the episode

EuroPCR 2024 - We are joined by Dr Mirvat Alasnag (King Fahd Armed Forces Hospital, SA) for a concise and insightful summary of the late-breaking trials that are expected to have an impact on structural heart disease care.

Trials covered in detail include:

  • IRONMAN II
  • DESyne BDS Plus
  • NOTION II
  • LANDMARK
  • PINNACLE

Recorded onsite at EuroPCR 2024, Paris

Overview

Our regular review series View From the Thoraxcenter, hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) dives deep into the late-breaking trials of EuroPCR 2023, spotlighting the impactful data.

For short, concise coverage of the key data revealed, our accessible Expert Interviews were conducted with select faculty, focussing on the results, applicability and impact on future research. 

Hear commentary on the practice-changing trials of EuroPCR 2024 from selected faculty in our Highlights Reviews.

Faculty Biographies

Mirvat Alasnag

Mirvat Alasnag

Director of Catheterization Laboratory

Dr. Mirvat Alasnag is a consultant interventional cardiologist based in Jeddah, Saudi Arabia. She is Director of the Catheterization Laboratory at King Fahad Armed Forces Hospital, where she has played a central role in the development of contemporary interventional cardiology services. Dr. Alasnag is recognised as the first female interventional cardiologist in the Gulf region and has been a prominent advocate for women in cardiology, representing female physicians on multiple national and international committees.

 

Academic History

Dr. Alasnag completed her training in Clinical Cardiology at Loma Linda University Medical Center in Loma Linda, California. She subsequently undertook advanced training in Interventional Cardiology at Harper University Hospital, Detroit Medical Center, in Detroit, Michigan. Her training combined high-volume clinical practice with exposure to complex coronary interventions, forming the foundation for her subsequent leadership…

View full profile

Comments

You must be to comment. If you are not registered, you can register here.